Advertisement

Helicobacter pylori

  • Hidekazu Suzuki
  • Robin Warren
  • Barry Marshall

Table of contents

  1. Front Matter
    Pages i-x
  2. History

    1. Front Matter
      Pages 1-1
  3. Pathogenesis

    1. Front Matter
      Pages 17-17
    2. Muhammad Miftahussurur, Yoshio Yamaoka
      Pages 19-32
    3. Yoshie Senda, Masanori Hatakeyama
      Pages 33-47
    4. Masayuki Nakano, Toshiya Hirayama, Joel Moss, Kinnosuke Yahiro
      Pages 49-66
    5. Hitoshi Tsugawa, Hidekazu Suzuki
      Pages 67-71
    6. Yoon Jin Choi, Nayoung Kim
      Pages 73-123
    7. Juntaro Matsuzaki, Hidekazu Suzuki
      Pages 125-130
    8. Masahiko Nakamura, Anders Øverby, Somay Y. Murayama, Hidekazu Suzuki, Tetsufumi Takahashi, Shinichi Takahashi et al.
      Pages 131-140
  4. Diagnosis

    1. Front Matter
      Pages 141-141
    2. Akiko Shiotani, Maria Pina Dore, David Y. Graham
      Pages 143-155
    3. Mototsugu Kato
      Pages 157-167
  5. Treatment

    1. Front Matter
      Pages 203-203
    2. Makoto Sasaki
      Pages 205-223
    3. Takahisa Furuta, Mitsushige Sugimoto, Mihoko Yamade, Takahiro Uotani, Shu Sahara, Hitomi Ichikawa et al.
      Pages 225-235
    4. Javier Molina-Infante
      Pages 237-252
    5. Toshihiro Nishizawa, Hidekazu Suzuki
      Pages 253-267

About this book

Introduction

This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP). Medical authorities worldwide now recommend a “test and treat” strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program.

This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.

Keywords

H. pylori infection MALT lymphoma eradication therapy gastric carcinoma gastric ulcer immune thrombocytopenic purpura

Editors and affiliations

  • Hidekazu Suzuki
    • 1
  • Robin Warren
    • 2
  • Barry Marshall
    • 3
  1. 1.Medical Education CenterKeio University School of MedicineTokyoJapan
  2. 2.The Royal Perth HospitalThe University of Western Australia andWestern AustraliaAustralia
  3. 3.The Royal Perth HospitalThe University of Western Australia andWestern AustraliaAustralia

Bibliographic information

  • DOI https://doi.org/10.1007/978-4-431-55705-0
  • Copyright Information Springer Japan 2016
  • Publisher Name Springer, Tokyo
  • eBook Packages Medicine
  • Print ISBN 978-4-431-55704-3
  • Online ISBN 978-4-431-55705-0
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology